{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:58:12Z","timestamp":1792835892067,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ijbiomac.2022.01.172","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T21:21:18Z","timestamp":1643750478000},"page":"19-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Shikonin impedes phase separation and aggregation of tau and protects SH-SY5Y cells from the toxic effects of tau oligomers"],"prefix":"10.1016","volume":"204","author":[{"given":"Anuradha","family":"Venkatramani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandipan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulal","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0015","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","volume":"8","author":"Violet","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.590059","article-title":"Much more than a cytoskeletal protein: physiological and pathological functions of the non-microtubule binding region of tau","volume":"11","author":"Brandt","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","article-title":"Molecular pathogenesis of the tauopathies","volume":"14","author":"G\u00f6tz","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12208","article-title":"Invited review: neuropathology of tauopathies: principles and practice","volume":"41","author":"Kovacs","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-160912","article-title":"Tau oligomers associate with inflammation in the brain and retina of tauopathy mice and in neurodegenerative diseases","volume":"55","author":"Nilson","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0050","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.595532","article-title":"Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation","volume":"11","author":"Alquezar","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0060","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijbiomac.2019.04.120","article-title":"Regulation of neuronal microtubule dynamics by tau: implications for tauopathies","volume":"133","author":"Venkatramani","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0070","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108884","article-title":"Pyridine-2,3-dicarboxylate, quinolinic acid, induces 1N4R tau amyloid aggregation in vitro: another evidence for the detrimental effect of the inescapable endogenous neurotoxin","volume":"315","author":"Esmaeili","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134919","article-title":"Targeting tau: clinical trials and novel therapeutic approaches","volume":"731","author":"VandeVrede","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0090","first-page":"643","article-title":"Targets and small molecules against tauopathies, part 1: from genes to soluble, aggregation-prone tau proteins","author":"Seneci","year":"2014","journal-title":"Drug Des. Discov. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024034","article-title":"Interactions between microtubule-associated protein tau (MAPT) and small molecules","volume":"7","author":"Rauch","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fcell.2019.00242","article-title":"Naphthoquinone tryptophan hybrids: a promising small molecule scaffold for mitigating aggregation of amyloidogenic proteins and peptides","volume":"7","author":"Viswanathan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0105","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/anie.200802621","article-title":"Development of tau aggregation inhibitors for Alzheimer\u2019s disease","volume":"48","author":"Bulic","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0110","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neuropharm.2010.01.016","article-title":"Tau protein and tau aggregation inhibitors","volume":"59","author":"Bulic","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0115","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-170351","article-title":"Curcumin inhibits tau aggregation and disintegrates preformed tau filaments in vitro","volume":"60","author":"Rane","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0120","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/acschemneuro.1c00098","article-title":"C1 inhibits liquid-liquid phase separation and oligomerization of tau and protects neuroblastoma cells against toxic tau oligomers","volume":"12","author":"Pradhan","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0125","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ijbiomac.2018.08.175","article-title":"Effective suppression of the modified PHF6 peptide\/1N4R tau amyloid aggregation by intact curcumin, not its degradation products: another evidence for the pigment as preventive\/therapeutic \u201cfunctional food\u201d","volume":"120","author":"Bijari","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0130","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","article-title":"Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial","volume":"388","author":"Gauthier","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer\u2019s disease: cohort analysis as modified primary outcome in a phase III clinical trial","volume":"61","author":"Wilcock","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108218","article-title":"The antidepressant drug; trazodone inhibits tau amyloidogenesis: prospects for prophylaxis and treatment of AD","volume":"679","author":"Akbari","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2010.06.027","article-title":"Shikonin protects mouse brain against cerebral ischemia\/reperfusion injury through its antioxidant activity","volume":"643","author":"Wang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.neuropharm.2008.06.065","article-title":"Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-\u03baB: neuroprotective implications","volume":"55","author":"Nam","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41598-017-18058-7","article-title":"Shikonin protects PC12 cells against \u03b2-amyloid peptide-induced cell injury through antioxidant and antiapoptotic activities","volume":"8","author":"Tong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000480474","article-title":"Effect of shikonin on spinal cord injury in rats via regulation of HMGB1\/TLR4\/NF-\u03baB signaling pathway","volume":"43","author":"Bi","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0165","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1042\/BCJ20190042","article-title":"An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization","volume":"476","author":"Rane","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0170","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.1073\/pnas.1633508100","article-title":"Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease","volume":"100","author":"Panda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0175","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/383550a0","article-title":"Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans","volume":"383","author":"Goedert","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/acschemneuro.9b00455","article-title":"The acetyl mimicking mutation, K274Q in tau, enhances the metal binding affinity of tau and reduces the ability of tau to protect DNA","volume":"11","author":"Rane","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0185","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/acschemneuro.1c00377","article-title":"Contrasting effects of ferric and ferrous ions on oligomerization and droplet formation of tau: implications in tauopathies and neurodegeneration","volume":"12","author":"Mukherjee","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0190","article-title":"Novel antibody against low-n oligomers of tau protein promotes clearance of tau in cells via lysosomes","volume":"6","author":"Chandupatla","year":"2020","journal-title":"Alzheimers Dement.(N. Y.)"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0195","doi-asserted-by":"crossref","DOI":"10.1063\/1.2432410","article-title":"WSXM: a software for scanning probe microscopy and a tool for nanotechnology","volume":"78","author":"Horcas","year":"2007","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0200","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0205","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1021\/acs.jmedchem.6b00101","article-title":"Novel Combretastatin-2-aminoimidazole analogues as potent tubulin assembly inhibitors: exploration of unique pharmacophoric impact of bridging skeleton and aryl moiety","volume":"59","author":"Chaudhary","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0210","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1074\/jbc.M410984200","article-title":"Anthraquinones inhibit tau aggregation and dissolve Alzheimer\u2019s paired helical filaments in vitro and in cells","volume":"280","author":"Pickhardt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0215","first-page":"35","article-title":"Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro","volume":"299","author":"Barghorn","year":"2005","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0220","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156720501209151019104951","article-title":"Identification of small molecule inhibitors of tau aggregation by targeting monomeric tau as a potential therapeutic approach for tauopathies","volume":"12","author":"Pickhardt","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0225","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid\u2013liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0230","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0091-679X(10)95017-6","article-title":"Fluorescence spectroscopic methods to analyze drug-tubulin interactions","volume":"95","author":"Bhattacharyya","year":"2010","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0235","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.11-199851","article-title":"Identification of oligomers at early stages of tau aggregation in Alzheimer\u2019s disease","volume":"26","author":"Lasagna-Reeves","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0240","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0245","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0250","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1038\/ncomms8025","article-title":"A mechanistic model of tau amyloid aggregation based on direct observation of oligomers","volume":"6","author":"Shammas","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0255","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1567205011666141107150331","article-title":"Structure and mechanism of action of tau aggregation inhibitors","volume":"11","author":"Cisek","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0260","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/bi0521543","article-title":"Global hairpin folding of tau in solution","volume":"45","author":"Jeganathan","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fneur.2013.00093","article-title":"Formation and propagation of tau oligomeric seeds","volume":"4","author":"Gerson","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0270","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-017-0298-7","article-title":"Propagation of tau aggregates","volume":"10","author":"Goedert","year":"2017","journal-title":"Mol. Brain."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0275","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nbd.2015.09.003","article-title":"Prefibrillar tau oligomers alter the nucleic acid protective function of tau in hippocampal neurons in vivo","volume":"82","author":"Violet","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0280","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","article-title":"Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease","volume":"287","author":"Saman","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100760","article-title":"Ectosomes: a new mechanism for non-exosomal secretion of tau protein","volume":"9","author":"Dujardin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3164\/jcbn.13-107","article-title":"Evaluation of radical scavenging properties of shikonin","volume":"55","author":"Yoshida","year":"2014","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.ijbiomac.2022.01.172_bb0295","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1083\/jcb.200108057","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J. Cell Biol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022001957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813022001957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:19:50Z","timestamp":1758878390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813022001957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":59,"alternative-id":["S0141813022001957"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.172","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shikonin impedes phase separation and aggregation of tau and protects SH-SY5Y cells from the toxic effects of tau oligomers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.01.172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}